IRTC IRhythm Technologies Inc.

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2025 Health Care Conference.

iRhythm’s management is scheduled to present on Tuesday, May 13, 2025, 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at .

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact

Stephanie Zhadkevich

Media Contact

Kassandra Perry



EN
29/04/2025

Underlying

IRTCIRhythm Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan...

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid a growing demand for early, accurate detection of arrhythmias in Japan, the second largest ambulatory cardiac monitoring market in the world, where the prevalence is expected to rise alon...

May 1, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies Announces First Quarter 2025 Financial Results

iRhythm Technologies Announces First Quarter 2025 Financial Results SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue of $158.7 million, a 20.3% increase compared to first quarter 2024Gross margin of 68.8%, a 250-basis point increase compared to first quarter 2024Unrestricted cash, cash equivalents, and marketable securities of $520....

May 1, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies to Present at the Bank of America Securities 2025...

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities 2025 Health Care Conference. iRhythm’s management is scheduled to present on Tuesday, May 13, 2025, 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presenta...

April 29, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring ...

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups.Latest data showed Zio LTCM was associated with higher diagnostic yield and lower likelihood of repeat testing and cardiovascular events compared to all other LTCM products. SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ:IRTC) announced res...

April 28, 2025 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies to Report First Quarter 2025 Financial Results on...

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference c...

April 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch